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Abstract
Background: Despite advances in antimicrobial and surgical therapy, septic arthritis remains a rheumatologic
emergency that can lead to rapid joint destruction and irreversible loss of function. In adults, Staphylococcus aureus
is the most common microorganism isolated from native joints. Streptococcus gordonii is a prominent member of
the viridans group of oral bacteria and is among the bacteria most frequently identified as being primary agent of
subacute bacterial endocarditis. To the best of our knowledge, Streptococcus gordonii has not yet been described
as agent of septic arthritis.
Case Presentation: We describe here two cases of septic arthritis due to Streptococcus gordonii. It gives us an
opportunity to review epidemiology, diagnosis criteria and management of septic arthritis.
Conclusion: Although implication of S. gordonii as aetiologic agent of subacute endocarditis is well known, this
organism is a rare cause of septic arthritis. In this case, the exclusion of associated endocarditis is warranted.
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Background
Despite advances in antimicrobial and surgical therapies,
septic arthritis remains a rheumatologic emergency that
can lead to rapid joint destruction and irreversible loss
of function. In adults, Staphylococcus aureus is the most
common microrganism isolated from native joints,
found in 40–60% of cases in large series [1]. After S.
aureus, β-hemolytic streptococci are common cause of
bacterial arthritis; in contrast, viridans streptococci are
rarely associated with joint infection [2]. Streptococcus
gordonii is a prominent member of the large category of
viridans streptococci of oral bacteria that prevails pri-
marily on tooth surface [3]. S. gordonii, among others, is
well known for its ability to colonise damaged heart valves
and is among the bacteria most frequently identified as
being primary aetiological agent of subacute bacterial
endocarditis [4]. However, to the best of our knowledge,
this species has not yet been described in the literature as
agent of septic arthritis (SA). We here describe two cases
of septic arthritis due to Streptococcus gordonii.
Case presentation
Case n°1
A 62-year-old man, born in Turkey, presented to the
Orthopaedics Clinic with a painful, erythematous and
swollen left knee that had appeared seven days prior to
examination. There was no history of fever or chills, no
prior history of dental care or any invasive procedure.
Past medical history revealed an occlusion of the left
central retinal vein (2003), atrial fibrillation, a history
of hypertension and hypercholesterolaemia. Current
medications included amiodarone, amlodipin and sim-
vastatin. Physical examination revealed poor dental sta-
tus, cardio-respiratory examination was normal (BP of
130/70 mmHg, HR of 60 bpm), as well as the abdominal
examination. Body temperature was checked at 37.5°C.
Examination of the left knee confirmed tenderness and
erythema associated with a joint effusion. Lab studies
disclosed a C-reactive protein (CRP) of 28.8 mg/dL, ele-
vated white blood cell count (WBC) (neutrophil count
of 10550 cells/mm3). Standard X-Ray of the left knee
showed osteoarthritis. Aspiration of the knee revealed
* Correspondence: jean.yombi@uclouvain.be
1Departement of Internal Medicine and Infectious Diseases, Cliniques
Universitaires Saint Luc, Université catholique de louvain, 10 avenue
hippocrate, Brussels 1200, Belgium
Full list of author information is available at the end of the article
© 2012 Yombi et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Yombi et al. BMC Infectious Diseases 2012, 12:215
http://www.biomedcentral.com/1471-2334/12/215
purulent fluid with a WBC count of 28800 cells/mm3
(90% of neutrophils) and absence of urate crystals. No
microorganism was observed on Gram-stain of the syn-
ovial fluid. Culture of this liquid yielded alpha-haemolytic
streptococci. The organism was identified by mass-
spectometry (MALDITOF) and Phoenix system (Becton
Dickinson, USA) as Streptococcus gordonii. Identification
was confirmed by (16S)rRNA gene sequencing. Blood cul-
tures remained negative after 5 days of incubation. Tra-
noesophageal ultrasound of the heart was normal.
Treatment for septic arthritis was undertaken, and
arthroscopic lavage of the joint performed. Microbiology
of the synovial biopsy and fluid collected during the pro-
cedure also revealed Streptococcus gordonii. All isolates
showed susceptibility to penicillin, ampicillin, cefotaxime,
erythromycin, clindamycin and vancomycin. Antibiotics
(ampicillin 2 g 4 hourly) were given intravenously for
2 weeks, and then switched to oral moxifloxacin 400 mg
od + rifampicin 600 mg/day for 2 weeks, for total treat-
ment duration of 4 weeks. Follow-up was satisfactory,
with a complete clinical and functional recovery.
Case n° 2
A 78-year-old female presented to the Orthopaedics
Clinic with painful swelling of the left knee that had
appeared 4 months prior to examination, with marked
worsening 4 weeks before admission. She described gen-
eral malaise and chills as well as a body temperature of
37.7°C. She denied any recent dental care or invasive
procedure. Her medical history was marked by degen-
erative arthritis of the left knee, treated with total knee
arthroplasty 9 months prior to presentation. She had a
quick and complete recovery after surgery. Her past
medical history consisted of Parkinson’s disease treated
with levodopa, depression treated with escitalopram,
past history of alcohol abuse, and compressive cervical
myelopathy which had been treated with surgery. Upon
examination, BP was 120/60 mmHg, HR 80 bpm, and
temperature 37,7°C. Cardiac examination revealed a
systolic murmur (2/6). Examination of the extremities
confirmed a warm and tender left knee with moderate
effusion. Lab tests disclosed a CRP of 10.25 mg/dL,
WBC-count was normal. CT-Scan of the knee reaveled a
suspicion of loosening of the prosthesis and enabled a
synovial-fluid aspiration. Investigation of the aspirate
showed WBC at 16300 cells/mm3 (92% of neutrophils).
Microscopic examination of Gram-stained synovial fluid
was negative for microorganisms. Pure culture of alpha-
hemolytic streptococci was recovered after 24 h of incu-
bation of synovial fluid inoculated into aerobic BACTEC
system. Organism was identified as viridans group
streptococci and later confirmed as Streptococcus gordonii
by (16S)rRNA gene sequencing (99,9% of identitity). This
orgainsm was recovered from other synovial fluid samples
by using the same technique, but multiple blood cultures
(Bacted system, Becton Dickinson, USA) remained sterile
after 15 days of incubation. Transoesophageal echocardi-
ography showed a vegetation on the aortic valve with
major aortic regurgitation. Diagnosis of aortic endocardi-
tis was thus confirmed. Gentamycin (5 mg/kg/day) and
oral rifampicin (900 mg/day) were thus added to the
treatment that had been started after synovial aspiration
(iv ampicillin 2 g 4-hourly).
Treatment for chronic post-operative prosthetic joint
infection was undertaken, i.e. removal of prosthesis, soft
tissue debridement and spacer. Culture of synovial bi-
opsy obtained during surgery yielded pure culture of S.
gordonii. The patient underwent aortic valve replace-
ment and then, a revision knee arthroplasty was per-
formed in a second operative time. Both surgeries had
an uncomplicated follow-up. The total duration of anti-
biotic (shifted to amoxicilline 3 g/day + rifampicin
900 mg/day) was 12 weeks.
Discussion
All major surveys on septic arthritis demonstrate that
predominant causative organisms of septic arthritis
are either staphylococci or streptococci [5-13]. These
organisms account for 91% of cases [6]. Gram-negative
organisms are more common in older or immunocom-
promised patients than in young adults. Anaerobic
organisms rarely cause septic arthritis, but are more com-
mon when there is a history of penetrating trauma [5,14].
The viridans group streptococci is however rarely the
causative agent of septic arthritis. S. viridans group is a
heterogenous group of organisms with complex and con-
troversial taxonomy. Today, this group is classified into
6 majors groups: S. mutans group, S. salivarius group,
S. anginosus group, S. mitis group and S. bovis group [15].
Based on phenotypic reactions, the S. mitis group can
be further divided into S. sanguinis (formely known as
S. sanguis) that includes S. gordonii, and S. mitis. The viri-
dans group streptococci are part of the commensal flora
and have low virulence, and infection with this micro-
organism usually appears on a previously injured focus
[2,15]. However, its association with dental caries and bac-
terial endocarditis has been well established [2,16]. Com-
prehensive reviews on the topic does not mention viridans
group streptococci as aetiological agents in septic arthritis
[5]. However, some isolated cases have been identified,
mainly affecting the knee, sternoclavicular, acromioclavi-
cular and sacroiliac joints [2,17-20]. In one of these cases,
septic arthritis was associated with bacterial endocarditis
[20]. Blankstein et al. [18] described a minor trauma
shortly preceding development of septic phenomenon.
Alpha-haemolytic streptococci have been implicated in 15
cases of spondylodiscitis, including S. mitis group (S. mitis
and S. sanguinis) and S. anginosus [21]. Other members
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of Streptococcus viridans from S. mitis group (S. sanguinis,
and S. oralis) have been described in case-reports as agent
of septic arthritis [22-24]. We found no case of Streptococcus
gordonii septic arthritis in modern literature.
Risk factors for development of joint sepsis include:
rheumatoid arthritis (RA) or osteoarthritis, prosthetic
joints, low socioeconomic status, intravenous drug abuse,
alcoholism, diabetes mellitus, previous intra-articular
corticosteroid injection and cutaneous ulcers [5].
A prospective community survey of bacterial arthritis
found that a number of factors seem to be associated
with poor prognosis. These include older age, pre-
existing joint disease and the presence of synthetic
material within the joint [25].
Septic arthritis typically presents as a hot, swollen, ten-
der joint or joints with a reduced range of movement.
Symptoms are usually present for less than 2 weeks at
presentation, but significant delay may occur, particularly
with low-virulence organisms, tuberculosis and prosthesis
infection. Large joints are more commonly reported than
small joints. In up to 60% of cases, the affected joints are
the hip or the knee [5,8,26,27]. When there is pre-existing
inflammatory joint disease, such as RA, symptoms in the
affected joint, or joints, are out of proportion to disease
activity detected in other joints [5].
Our first patient is an older patient with poor dental
status. We postulated that he experienced transitory bac-
teriaemia (despite the fact that multiple blood cultures
upon admission were negative) and that pre-existing se-
vere degenerative arthritis of the knee promoted bacter-
ial graft on that focus. The second patient is also an
older woman with pre-existing valvulopathy and knee
arthroplasty. We also postulated that she experienced
transitory bacteriaemia and developed endocarditis and
prosthetic joint infection.
Prompt microscopic analysis and culture of synovial
fluid are fundamental diagnostic tools in the evaluation of
possible joint sepsis, enabling diagnosis (of both sepsis and
crystal-induced arthritis) to be confirmed rapidly. Culture
is more sensitive than microscopy alone, as synovial fluid
Gram-staining is positive in only 50% of cases.
Cytology performed on synovial fluid shows WBC-
count of 100.000 cells/mm3 on average (between 25000
and 250000 cells/mm3). A cell-count of more than
50.000 cells/mm3 with more than 90% of neutrophils
makes the diagnosis of septic arthritis highly probable
[28]. Coutlakis et al., in their retrospective study on 202
patients, showed that when cell-count on synovial fluid
is over 100.000/mm3, 77% of patients had septic arth-
ritis, while 47% of patients were diagnosed with SA if
cell-count was between 50.000 and 100.000/mm3. Below
the 50.000/mm3-cut-off, diagnosis of SA was less probable
[29], though it does not exclude it. A septic arthritis with
a WBC-count < 25.000/mm3 can be encountered mainly
in patients with a history of cancer, those on corticoster-
oids or in iv-drug abuser, though neutrophil-count
remains higher than 90%. In knee arthroplasty, a synovial
fluid leucocyte-count of more than 1.7 × 103/mm3 had a
sensitivity of 94% and a specificity of 88% for prosthetic
joint infection (PJI) [30]. Synovial polymorphonuclear
neutrophil differential higher than 65% had a sensitivity
of 94% and a specificity of 98% for PJI.
Synovial fluid aspiration also enables a search for
crystals, to exclude gout or microcrystalline arthritis.
Other laboratory studies can be performed, like glucose
levels: (SA : glucose < 40 mg/dL or 50% of glycemia) or
lactates (high levels). Though they are not specific, they
make diagnosis of septic arthritis more likely [31,32].
The cornerstone of rapid and reliable confirmation of
diagnosis of suspected septic arthritis is microbiological
examination of synovial fluid. The sensitivity for detec-
tion of a causative organisms is, however, often disap-
pointing. It is generally accepted that samples of freshly
aspirated joint fluid should be sent to the laboratory for
immediate analysis. Different factors have been impli-
cated in the failure to detect the causative organism
from patients with septic arthritis including small vol-
ume of cultured specimen, purulent exudates that could
play an inhibitory effect on bacterial grownth and lower
concentration of bacteria in synovial fluid. In this matter,
inoculation of synovial fluid into blood culture medium
such as BACTEC system (Becton Dickinson diagnostic
instrument systems) or paediatric isolator tubes enhances
recovery of microorganisms. Inoculation of sterile sam-
ples such as synovial fluid directly into BACTEC system
is a usual practice in our institution and yielded the
aetiologic agent in the two above-mentionned cases.
Identification of viridans group streptococci remains
difficult by currently manual or automated methods.
This, together with taxonomic problems in this group of
organisms, have made identification at the species level
not always accurate and frequently absent in many
reported cases of septic arthritis by viridans group strepto-
cocci. Matrix-associated laser desorption ionization-time
of fligtht (MALDITOF) is a rapid and cost-effective tool
for identification of bacteria cultures. Recent studies
comparing ability of this system with biochemical ana-
lyses showed that MALDITOF appeared to be a rapid
and accurate mode of viridans group streptococci identi-
fication [33]. This method yielded the correct identifica-
tion of S. gordonii in our patients as confirmed by 16S
rRNA gene sequence analysis.
Treatment of septic arthritis differs depending on the
joint: native vs prosthetic joint. Prompt treatment with
antibiotics together with removal of any purulent mater-
ial is the mainstay of treatment for septic arthritis.
There is little evidence on which to base the choice
and duration of antibiotic treatment, and we found no
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prospective randomised, controlled trials. One system-
atic review and meta-analysis of antibiotic treatment
for joint infections showed no advantage on clinical or
bacteriological efficacy of one antibiotic regimen over
another [34]. Currently, the choice of antibiotic is based
on the likelihood of the organism involved modified by
results of Gram-staining and culture.
Removal of purulent materiel can be achieved either
surgically or through closed needle aspiration. There is
controversy over which mode of drainage should be
used. Recently, Butt et al. found that 77% of rheumatolo-
gists and 66% of orthopaedic surgeons (OS) in the UK
recommended surgical joint drainage; 22% and 27%,
respectively, recommended repeated closed needle aspir-
ation as their chosen method of joint drainage [35].
However, Ravindran et al., in a recent study comparing
medical treatment (serial closed-needle aspiration) and
surgical treatment (arthroscopy/arthrotomy combined
with joint washout), showed that for native joint SA,
surgical treatment was not superior to medical treat-
ment and, therefore, highlighted the need for careful
case selection for surgical intervention [36].
Antimicrobial therapy without implant removal in
streptococcal prosthetic joint infections has been
reported to be successful in 45 of 63 cases (71%) [37].
Everts et al., in their study on PJI due to Streptococcus
treated with antimicrobial therapy and retention of im-
plant, found a success rate of 94% [37]. Streptococcus
viridans PJI treated with primary antibiotic and implant
retention showed success in 8 of 10 cases (80%) [37].
However, some criteria must be respected: stable im-
plant, acute infection with symptom duration of less
than 3 weeks and the patient should tolerate long-term
antimicrobial therapy. In our second case, we decided to
perform a two-stages surgery because symptoms were
present for 4 weeks and X-ray showed suspicion of
implant loosening.
Conclusions
We can conclude that, although implication of S. gordonii
as aetiologic agent of subacute endocarditis is well known,
this organism is a rare cause of septic arthritis. In this case,
the exclusion of associated endocarditis is warranted. The
prognosis of septic arthritis caused by S. gordonii appears
to be favourable when a rapid approach including drain-
age of the joint, removal of any prosthesis and antibiotic
therapy is undertaken.
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